Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03523572
Title Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | BEL


No variant requirements are available.